Article
TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices.
Brain pathology (Zurich, Switzerland) - 1 Jul 2015
Lue Lih-Fen, Schmitz Christopher T, Serrano Geidy, Sue Lucia I, Beach Thomas G, Walker Douglas G
Abstract excerpt
Triggering receptor expressed by myeloid cells 2 (TREM2), a member of the immunoglobulin superfamily, has anti-inflammatory phagocytic function in myeloid cells. Several studies have shown that TREM2 gene variant rs75932628-T increased the risks for Alzheimer's disease (AD), Parkinson's disease, frontotemporal dementia and amyotrophic lateral sclerosis. It has been suggested that the risks could be resulted from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
